Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10549-013-2556-4.

Title:
FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast | Breast Cancer Research and Treatment
Description:
FOXP3-expressing T regulatory lymphocytes (Tregs) have been described as putative mediators of immune tolerance, and thus facilitators of tumor growth. When found in association with various malignancies, Tregs are generally markers of poor clinical outcome. However, it is unknown whether they are also associated with cancer progression. We evaluated quantitative FOXP3 expression in lymphocytes as well as in epithelial cells in a set of thirty-two breast tumors with synchronous normal epithelium, ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC) components. Tumors were stained for FOXP3 and CD3 expression and Tregs quantified by determining the ratio of colocalized FOXP3 and CD3 relative to 1) total CD3-expressing lymphocytes and 2) to FOXP3-expressing epithelial cells. The median proportion of FOXP3-expressing CD3 cells significantly increased with malignant progression from normal to DCIS to IDC components (0.005, 0.019 and 0.030, respectively; p ≤ 0.0001 for normal vs. IDC and p = 0.004 for DCIS vs. IDC). The median intensity of epithelial FOXP3 expression was also increased with invasive progression and most markedly augmented between normal and DCIS components (0.130 vs. 0.175, p ≤ 0.0001). Both Treg infiltration and epithelial FOXP3 expression were higher in grade 3 vs. grade 1 tumors (p = 0.014 for Tregs, p = 0.038 for epithelial FOXP3), but did not vary significantly with hormone receptor status, size of invasive tumor, lymph node status, or disease stage. Notably, Treg infiltration significantly correlated with epithelial up-regulation of FOXP3 expression (p = 0.013 for normal, p = 0.001 for IDC). These findings implicate both Treg infiltration and up-regulated epithelial FOXP3 expression in breast cancer progression.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Health & Fitness
  • Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't tell how the site generates income.

The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, article, pubmed, google, scholar, foxp, cas, breast, regulatory, cells, res, expression, carcinoma, usa, epithelial, ductal, san, research, lymphocytes, patients, cell, francisco, normal, invasive, tumor, progression, department, situ, chen, waldman, idc, access, clin, liu, university, privacy, cookies, content, lal, frederic, hwang, tregs, dcis, increased, infiltration, receptor, tumorinfiltrating, immunol, survival, blood,

Topics {✒️}

month download article/chapter tumor-infiltrating foxp3-positive regulatory tumor-draining lymph nodes total cd3-expressing lymphocytes tumor-infiltrating t-lymphocytes pancreatic ductal adenocarcinoma foxp3 expressing cd4 + cd25 late-stage ovarian cancer transcription factor foxp3 foxp3-expressing epithelial cells recruit foxp3+treg cells full article pdf regulatory t-cell function yunn-yi chen privacy choices/manage cookies hormone receptor status histone deacetylase inhibitors poor clinical outcome pancreatic carcinoma cells histone deacetylase expression breast cancer due breast cancer survival predicts reduced survival foxp3-positive regulatory invasive breast carcinoma invasive ductal carcinoma european economic area lymph node status related subjects tumor-infiltrating lymphocytes foxp3+ tumor-infiltrating synchronous normal epithelium breast cancer progression tamoxifen-stimulated growth breast oncology program article lal site-specific inhibition functionally regulates response ten hoor ka sps apollo hospitals t-regulatory cells koei chin & frederic foxp3 defines regulatory cell lineage commitment breast adenocarcinoma conditions privacy policy epithelial foxp3 expression san juan capistrano induce allograft tolerance conejo-garcia jr

Schema {🗺️}

WebPage:
      mainEntity:
         headline:FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
         description:FOXP3-expressing T regulatory lymphocytes (Tregs) have been described as putative mediators of immune tolerance, and thus facilitators of tumor growth. When found in association with various malignancies, Tregs are generally markers of poor clinical outcome. However, it is unknown whether they are also associated with cancer progression. We evaluated quantitative FOXP3 expression in lymphocytes as well as in epithelial cells in a set of thirty-two breast tumors with synchronous normal epithelium, ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC) components. Tumors were stained for FOXP3 and CD3 expression and Tregs quantified by determining the ratio of colocalized FOXP3 and CD3 relative to 1) total CD3-expressing lymphocytes and 2) to FOXP3-expressing epithelial cells. The median proportion of FOXP3-expressing CD3 cells significantly increased with malignant progression from normal to DCIS to IDC components (0.005, 0.019 and 0.030, respectively; p ≤ 0.0001 for normal vs. IDC and p = 0.004 for DCIS vs. IDC). The median intensity of epithelial FOXP3 expression was also increased with invasive progression and most markedly augmented between normal and DCIS components (0.130 vs. 0.175, p ≤ 0.0001). Both Treg infiltration and epithelial FOXP3 expression were higher in grade 3 vs. grade 1 tumors (p = 0.014 for Tregs, p = 0.038 for epithelial FOXP3), but did not vary significantly with hormone receptor status, size of invasive tumor, lymph node status, or disease stage. Notably, Treg infiltration significantly correlated with epithelial up-regulation of FOXP3 expression (p = 0.013 for normal, p = 0.001 for IDC). These findings implicate both Treg infiltration and up-regulated epithelial FOXP3 expression in breast cancer progression.
         datePublished:2013-05-28T00:00:00Z
         dateModified:2013-05-28T00:00:00Z
         pageStart:381
         pageEnd:390
         sameAs:https://doi.org/10.1007/s10549-013-2556-4
         keywords:
            FOXP3
            Lymphocytes
            Epithelium
            Breast cancer
            Ductal carcinoma in situ
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig4_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig5_HTML.gif
         isPartOf:
            name:Breast Cancer Research and Treatment
            issn:
               1573-7217
               0167-6806
            volumeNumber:139
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Aseem Lal
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
                     name:SPS Apollo Hospitals
                     address:
                        name:Department of Pathology, SPS Apollo Hospitals, Ludhiana, India
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Loretta Chan
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sandy DeVries
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Koei Chin
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
                     name:Oregon Health and Science University
                     address:
                        name:Department of Biomedical Engineering, Oregon Health and Science University, Portland, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Gary K. Scott
               affiliation:
                     name:Buck Institute for Research on Aging
                     address:
                        name:Buck Institute for Research on Aging, Novato, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Christopher C. Benz
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Medicine and Oncology/Hematology, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
                     name:Buck Institute for Research on Aging
                     address:
                        name:Buck Institute for Research on Aging, Novato, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yunn-Yi Chen
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Pathology, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Frederic M. Waldman
               affiliation:
                     name:University of California San Francisco
                     address:
                        name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
                     name:University of California San Francisco
                     address:
                        name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
                        type:PostalAddress
                     type:Organization
                     name:Quest Diagnostics Nichols Institute
                     address:
                        name:Quest Diagnostics Nichols Institute, San Juan Capistrano, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:E. Shelley Hwang
               affiliation:
                     name:Duke University
                     address:
                        name:Department of Surgery, Duke University, Durham, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:FOXP3-positive regulatory T lymphocytes and epithelial FOXP3 expression in synchronous normal, ductal carcinoma in situ, and invasive cancer of the breast
      description:FOXP3-expressing T regulatory lymphocytes (Tregs) have been described as putative mediators of immune tolerance, and thus facilitators of tumor growth. When found in association with various malignancies, Tregs are generally markers of poor clinical outcome. However, it is unknown whether they are also associated with cancer progression. We evaluated quantitative FOXP3 expression in lymphocytes as well as in epithelial cells in a set of thirty-two breast tumors with synchronous normal epithelium, ductal carcinoma in situ (DCIS), and invasive ductal carcinoma (IDC) components. Tumors were stained for FOXP3 and CD3 expression and Tregs quantified by determining the ratio of colocalized FOXP3 and CD3 relative to 1) total CD3-expressing lymphocytes and 2) to FOXP3-expressing epithelial cells. The median proportion of FOXP3-expressing CD3 cells significantly increased with malignant progression from normal to DCIS to IDC components (0.005, 0.019 and 0.030, respectively; p ≤ 0.0001 for normal vs. IDC and p = 0.004 for DCIS vs. IDC). The median intensity of epithelial FOXP3 expression was also increased with invasive progression and most markedly augmented between normal and DCIS components (0.130 vs. 0.175, p ≤ 0.0001). Both Treg infiltration and epithelial FOXP3 expression were higher in grade 3 vs. grade 1 tumors (p = 0.014 for Tregs, p = 0.038 for epithelial FOXP3), but did not vary significantly with hormone receptor status, size of invasive tumor, lymph node status, or disease stage. Notably, Treg infiltration significantly correlated with epithelial up-regulation of FOXP3 expression (p = 0.013 for normal, p = 0.001 for IDC). These findings implicate both Treg infiltration and up-regulated epithelial FOXP3 expression in breast cancer progression.
      datePublished:2013-05-28T00:00:00Z
      dateModified:2013-05-28T00:00:00Z
      pageStart:381
      pageEnd:390
      sameAs:https://doi.org/10.1007/s10549-013-2556-4
      keywords:
         FOXP3
         Lymphocytes
         Epithelium
         Breast cancer
         Ductal carcinoma in situ
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig4_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10549-013-2556-4/MediaObjects/10549_2013_2556_Fig5_HTML.gif
      isPartOf:
         name:Breast Cancer Research and Treatment
         issn:
            1573-7217
            0167-6806
         volumeNumber:139
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Aseem Lal
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
                  name:SPS Apollo Hospitals
                  address:
                     name:Department of Pathology, SPS Apollo Hospitals, Ludhiana, India
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Loretta Chan
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sandy DeVries
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Koei Chin
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
                  name:Oregon Health and Science University
                  address:
                     name:Department of Biomedical Engineering, Oregon Health and Science University, Portland, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Gary K. Scott
            affiliation:
                  name:Buck Institute for Research on Aging
                  address:
                     name:Buck Institute for Research on Aging, Novato, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Christopher C. Benz
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Medicine and Oncology/Hematology, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
                  name:Buck Institute for Research on Aging
                  address:
                     name:Buck Institute for Research on Aging, Novato, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yunn-Yi Chen
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Pathology, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Frederic M. Waldman
            affiliation:
                  name:University of California San Francisco
                  address:
                     name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
                  name:University of California San Francisco
                  address:
                     name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
                     type:PostalAddress
                  type:Organization
                  name:Quest Diagnostics Nichols Institute
                  address:
                     name:Quest Diagnostics Nichols Institute, San Juan Capistrano, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:E. Shelley Hwang
            affiliation:
                  name:Duke University
                  address:
                     name:Department of Surgery, Duke University, Durham, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Breast Cancer Research and Treatment
      issn:
         1573-7217
         0167-6806
      volumeNumber:139
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of California San Francisco
      address:
         name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:SPS Apollo Hospitals
      address:
         name:Department of Pathology, SPS Apollo Hospitals, Ludhiana, India
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:Oregon Health and Science University
      address:
         name:Department of Biomedical Engineering, Oregon Health and Science University, Portland, USA
         type:PostalAddress
      name:Buck Institute for Research on Aging
      address:
         name:Buck Institute for Research on Aging, Novato, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Medicine and Oncology/Hematology, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:Buck Institute for Research on Aging
      address:
         name:Buck Institute for Research on Aging, Novato, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Pathology, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:University of California San Francisco
      address:
         name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
         type:PostalAddress
      name:Quest Diagnostics Nichols Institute
      address:
         name:Quest Diagnostics Nichols Institute, San Juan Capistrano, USA
         type:PostalAddress
      name:Duke University
      address:
         name:Department of Surgery, Duke University, Durham, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Aseem Lal
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
            name:SPS Apollo Hospitals
            address:
               name:Department of Pathology, SPS Apollo Hospitals, Ludhiana, India
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Loretta Chan
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Sandy DeVries
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Koei Chin
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
            name:Oregon Health and Science University
            address:
               name:Department of Biomedical Engineering, Oregon Health and Science University, Portland, USA
               type:PostalAddress
            type:Organization
      name:Gary K. Scott
      affiliation:
            name:Buck Institute for Research on Aging
            address:
               name:Buck Institute for Research on Aging, Novato, USA
               type:PostalAddress
            type:Organization
      name:Christopher C. Benz
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Medicine and Oncology/Hematology, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
            name:Buck Institute for Research on Aging
            address:
               name:Buck Institute for Research on Aging, Novato, USA
               type:PostalAddress
            type:Organization
      name:Yunn-Yi Chen
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Pathology, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
      name:Frederic M. Waldman
      affiliation:
            name:University of California San Francisco
            address:
               name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
            name:University of California San Francisco
            address:
               name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
               type:PostalAddress
            type:Organization
            name:Quest Diagnostics Nichols Institute
            address:
               name:Quest Diagnostics Nichols Institute, San Juan Capistrano, USA
               type:PostalAddress
            type:Organization
      name:E. Shelley Hwang
      affiliation:
            name:Duke University
            address:
               name:Department of Surgery, Duke University, Durham, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
      name:Department of Pathology, SPS Apollo Hospitals, Ludhiana, India
      name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
      name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
      name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
      name:Department of Biomedical Engineering, Oregon Health and Science University, Portland, USA
      name:Buck Institute for Research on Aging, Novato, USA
      name:Department of Medicine and Oncology/Hematology, University of California San Francisco, San Francisco, USA
      name:Buck Institute for Research on Aging, Novato, USA
      name:Department of Pathology, University of California San Francisco, San Francisco, USA
      name:Department of Laboratory Medicine, University of California San Francisco, San Francisco, USA
      name:Department of Cancer Center, University of California San Francisco, San Francisco, USA
      name:Quest Diagnostics Nichols Institute, San Juan Capistrano, USA
      name:Department of Surgery, Duke University, Durham, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(128)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.15s.